Scibase AB
SciBase Holding AB (publ), a medical technology company, develops and commercializes point-of-care platforms for skin health management in Europe, the United States, North America, Asia, Oceania, and internationally. It operates through Skin Cancer and Skin Barrier Assessment segments. The company offers Nevisense and Nevisense Go point-of-care platforms to detect melanoma and non-melanoma skin c… Read more
Scibase AB (SCIB) - Total Liabilities
Latest total liabilities as of September 2025: Skr20.50 Million SEK
Based on the latest financial reports, Scibase AB (SCIB) has total liabilities worth Skr20.50 Million SEK as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Scibase AB - Total Liabilities Trend (2012–2024)
This chart illustrates how Scibase AB's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Scibase AB Competitors by Total Liabilities
The table below lists competitors of Scibase AB ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Infrared Cameras Holdings Inc
NASDAQ:MSAI
|
USA | $3.59 Million |
|
Solueta Co Ltd
KQ:154040
|
Korea | ₩31.52 Billion |
|
General Environmental Management Inc
PINK:GEVI
|
USA | $3.75 Million |
|
Alianza Minerals Ltd
OTCQB:TARSF
|
USA | $590.02K |
|
Phol Dhanya Public Company Limited
BK:PHOL
|
Thailand | ฿265.30 Million |
|
Careplus Group Bhd
KLSE:0163
|
Malaysia | RM71.48 Million |
|
Cielo Waste Solutions Corp
PINK:CWSFF
|
USA | $4.48 Million |
|
Organic Tea Cosmetics Holdings Company Limited
KQ:900300
|
Korea | ₩73.67 Billion |
Liability Composition Analysis (2012–2024)
This chart breaks down Scibase AB's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.49 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 1.23 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.61 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.38 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Scibase AB's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Scibase AB (2012–2024)
The table below shows the annual total liabilities of Scibase AB from 2012 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | Skr25.08 Million | +17.87% |
| 2023-12-31 | Skr21.28 Million | -13.56% |
| 2022-12-31 | Skr24.62 Million | +67.92% |
| 2021-12-31 | Skr14.66 Million | +18.31% |
| 2020-12-31 | Skr12.39 Million | -12.42% |
| 2019-12-31 | Skr14.15 Million | +46.84% |
| 2018-12-31 | Skr9.63 Million | -20.95% |
| 2017-12-31 | Skr12.19 Million | -114.63% |
| 2016-12-31 | Skr-83.30 Million | -39.71% |
| 2015-12-31 | Skr-138.17 Million | -1641.01% |
| 2014-12-31 | Skr8.97 Million | +19.58% |
| 2013-12-31 | Skr7.50 Million | -84.23% |
| 2012-12-31 | Skr47.56 Million | -- |